## Abstract ## BACKGROUND In the United States, Blacks who smoke cigarettes have a higher mean blood concentration of the nicotine metabolite cotinine than White smokers. It has not been determined whether there are racial differences in the exposure to the cigarette smoke carcinogen 4‐(methylnitr
Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer
✍ Scribed by Kiersten S. Derby; Kristine Cuthrell; Christian Caberto; Steven Carmella; Sharon E. Murphy; Stephen S. Hecht; Loïc Le Marchand
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- French
- Weight
- 93 KB
- Volume
- 125
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Native Hawaiian smokers are at higher risk and Japanese‐American smokers at lower risk of lung cancer (LC), compared with white smokers, even after accounting for smoking history. Because variation in carcinogen exposure/metabolism may occur separately of smoking amount, we compared urinary biomarkers of uptake and detoxification of 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK)—a potent lung carcinogen—among 578 smokers in these ethnic/racial groups in Hawaii. We measured the NNK metabolite 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL) and its glucuronide (NNAL‐Gluc) and examined total NNAL (NNAL + NNAL‐Gluc) and the NNAL detoxification ratio (NNAL‐Gluc:NNAL). Native Hawaiians and Japanese–Americans had lower age‐ and sex‐adjusted mean total NNAL, compared with whites. When further adjusting for urinary nicotine equivalents (the sum of nicotine, cotinine, trans‐3′‐hydroxycotinine and their respective glucuronides), only the difference between Japanese–Americans and whites was eliminated. Therefore, consistent with their lower LC risk, a lower cigarette smoke exposure explains the lower NNK dose of Japanese–Americans, but it does not explain that of Native Hawaiians. The mean detoxification ratio was also lower in Native Hawaiians and Japanese–Americans, compared with whites, even after adjusting for nicotine equivalents (p < 0.0001). Lower NNAL glucuronidation in Native Hawaiians might contribute to their increased LC risk; however, this is inconsistent with the low glucuronidation ratio similarly observed in the low‐risk Japanese‐American group and because Native Hawaiians had lower total NNAL levels. Thus, exposure and detoxification of NNK are unlikely to explain, by themselves, the differences in LC risk among the 3 populations studied. © 2009 UICC
📜 SIMILAR VOLUMES
## Abstract Urinary metabolites of the tobacco‐specific nitrosamine 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK), 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanol (NNAL) and its glucuronides, termed total NNAL, have recently been shown to be good predictors of lung cancer risk, years before di
## Abstract To investigate the influence of different types of metabolic activation (9,000 x __g__ supernatant (S9) activation vs. a host‐mediated approach) on 4‐(methylnitrosamino)‐1‐(3‐pyridyl)‐1‐butanone (NNK)‐induced mutational specificity, we determined by DNA sequencing the distribution of fo